A considerable number of agents have been proposed as causing ligneous conjunctivitis. We report the first case to arise as a side effect of tranexamic acid (Cyclokapron), an antifibrinolytic drug used in the treatment of menorrhagia. In addition to the typical conjunctival changes our patient had lesions affecting the gingiva and the peritoneum the last causing considerable protein loss into the peritoneal cavity.
Ligneous conjunctivitis is a rare form of membranous conjunctivitis of unknown aetiology. ' The disease classically presents with the appearance of thickened, 'wood-like' membranes covering the tarsal conjunctiva. Other mucus membranes may also become involved, including the middle ear, buccal mucosa, nasopharynx, larynx, vocal cords, trachea, vagina, and cervix.'" We report a case of ligneous conjunctivitis in a young woman with Epstein's syndrome with involvement both of the gingiva and the peritoneum, caused by tranexamic acid (Cyclokapron).
Case report
In March 1990 a 25-year-old Caucasian woman presented to the Bristol Eye Hospital with a ninemonth history of ocular irritation and sticky discharge. On examination she had swollen eyelids with thickened, pale membranes adherent to the tarsal conjunctiva (Fig 1) . Surgical debridement revealed the underlying conjunctiva to be hyperaemic and haemorrhagic, though it was rapidly coated as the membranes reformed. She also had generalised gingival hyperplasia with shallow ulcers predominantly at the gingival margin (Fig 1) . Her ears, nasopharynx, larynx, vagina, and cervix were normal.
Three years earlier a diagnosis of Epstein Histological examination of the conjunctival membranes revealed masses of fibrin with collections of inflammatory cells, plus islands of entrapped epithelial cells (Fig 1) . Gingival biopsy revealed hyperkeratosis and reactive thickening with ulceration and pronounced fibrin leakage, oedema, and fibrosis (Fig 1) .
Over the following three months topical ocular 
